Axsome Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Axsome Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Axsome Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $5.73M, a 18.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.73M -$1.34M -18.9% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $6.07M -$1.34M -18.1% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $6.41M +$6.31M +5948% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $6.77M +$6.35M +1512% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $7.07M +$6.68M +1738% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $7.41M +$6.74M +1010% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $106K -$840K -88.8% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $420K -$240K -36.4% Dec 31, 2022 10-K 2024-02-23
Q3 2022 $385K -$552K -58.9% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $668K -$541K -44.8% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $946K -$530K -35.9% Mar 31, 2022 10-Q 2022-05-02
Q4 2021 $660K -$1.08M -62% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $937K Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $1.21M Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $1.48M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $1.74M Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.